Immunosuppression During Influenza Virus Infection

AUTOR(ES)

Kantzler, G. B.

RESUMO

The effects of a live attenuated influenza vaccine and subsequent challenge with virulent influenza virus on the delayed hypersensitivity skin test, and the in vitro response of lymphocytes were evaluated. Volunteers were skin tested before and after administration of vaccine or placebo and challenge with PPD (a purified protein derivative of Mycobacterium tuberculosis), candida, mumps, and trichophytin, and their lymphocytes were tested for [3H]thymidine uptake in response to phytohemagglutin. Of eight volunteers who showed evidence of viral replication after administration of the attenuated vaccine, four had a significant diminution in their skin test response, whereas 8 of 13 volunteers infected with virulent influenza virus showed a diminution. Of the 21 volunteers who were infected with either attenuated or virulent influenza virus, 12 showed suppression of their phytohemagglutin response. None of the volunteers who were given placebo vaccine, or who showed no evidence for viral replication after immunization or challenge, had a suppression of their skin test or phytohemagglutin responses. Although most of the infected volunteers demonstrated suppression of their T-cell function, there was no evidence of a similar suppression of B-cell function.

Documentos Relacionados

• Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression.
• Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection.
• Pulmonary antibacterial defenses during mild and severe influenza virus infection.
• Modification of eukaryotic initiation factor 4F during infection by influenza virus.
• Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.